Cargando…
A pharmacological perspective of chloroquine in SARS-CoV-2 infection: An old drug for the fight against a new coronavirus?
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is having serious consequences on health and the economy worldwide. All evidence-based treatment strategies need to be considered to combat this new virus. Drugs need to be conside...
Autores principales: | Oscanoa, Teodoro J., Romero-Ortuno, Roman, Carvajal, Alfonso, Savarino, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V. and International Society of Chemotherapy.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334645/ https://www.ncbi.nlm.nih.gov/pubmed/32629115 http://dx.doi.org/10.1016/j.ijantimicag.2020.106078 |
Ejemplares similares
-
Hepatic disorders associated with the use of Ivermectin for SARS-CoV-2 infection in adults: a pharmacovigilance study in VigiBase
por: Oscanoa, Teodoro J., et al.
Publicado: (2022) -
Frequency of Long QT in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine: A Meta-analysis
por: Oscanoa, Teodoro J., et al.
Publicado: (2020) -
Fighting Plasmodium chloroquine resistance with acetylenic chloroquine analogues
por: Cortopassi, Wilian A., et al.
Publicado: (2022) -
Effects of chloroquine on viral infections: an old drug against today's diseases
por: Savarino, Adrea, et al.
Publicado: (2003) -
Hepatotoxicity induced by isoniazid in patients with latent tuberculosis infection: a meta-analysis
por: Oscanoa, Teodoro J., et al.
Publicado: (2023)